VX-840
VX21-840-001
Phase 1 small_molecule completed
Quick answer
VX-840 for APOL1-mediated Kidney Disease is a Phase 1 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- APOL1-mediated Kidney Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed